Clinical trials
Phase 1 Hypercholesterolemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 8 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Recruiting | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 6 |
| AstraZeneca | 5 |
| Sanofi | 4 |
| Merck Sharp & Dohme LLC | 3 |
| Novartis Pharmaceuticals | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Afexa Life Sciences Inc | 1 |
| Arbutus Biopharma Corporation | 1 |
| Avera McKennan Hospital & University Health Center | 1 |
| CRISPR Therapeutics AG | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 40 |
| Dyslipidemias | 11 |
| Hyperlipidemias | 5 |
| Hypertension | 4 |
| Diabetes Mellitus | 3 |
| Aneurysm | 2 |
| Coronary Artery Disease | 2 |
| Hypertriglyceridemia | 2 |
| Lipid Metabolism Disorders | 2 |
| Metabolic Diseases | 2 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.